Navigation Links
Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinson's Disease
Date:10/14/2008

- Five research teams selected to receive funding for preclinical and

clinical research projects in Parkinson's disease-related cognitive

deficits and mood disorders

ROCKLAND, Mass., Oct. 14 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded a total of $2 million to five research teams to speed development of effective therapies for the under-addressed cognitive and mood-related symptoms of Parkinson's disease (PD). The award was made possible by leadership funding from EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany.

The research grants will support preclinical and clinical projects under MJFF's Cognitive Deficits and Mood Disorders in Parkinson's Disease initiative. Patients often report these symptoms, which range from problems with executive function (the ability to formulate, sequence, and execute plans) to dementia; depression, apathy and anxiety; and behavioral issues including problems with impulse control, to be among the most difficult aspects of living with PD.

"Clinicians and patients alike report how disabling the cognitive and mood effects of PD can be, yet these symptoms are systematically under-researched and are poorly understood," said Katie Hood, CEO of The Michael J. Fox Foundation. "We are thrilled to have found a like-minded partner in EMD Serono so that we can push this work forward."

Elmar Schnee, Merck's Executive Board Member responsible for Pharmaceuticals, said: "We recognize the critical need for new therapies to alleviate PD-related cognitive dysfunction. We are pleased to stand side by side with The Michael J. Fox Foundation in prioritizing and supporting research with potential to help speed development of effective treatments that will allow every patient to live a fuller and more satisfying life."

The development of treatments for cognitive and mood symptoms of PD has been hindered by a lack of preclinical mod
'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
3. Genstar Names Michael Hurt to Its Strategic Advisory Board
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
8. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
9. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
10. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
11. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...24 /PRNewswire-Asia/ -- Shanghai Biolaxy announced...(SFDA) has approved the,investigational new drug a...lin), an innovative insulin formulation to treat d...ate its first phase I clinical study. , D... glucose and poor,metabolism. The complications of...
(Date:11/24/2009)...ndpoint has been met for patients with advanced-st...EBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced positive efficacy data from a Phase 2 study wi...108 (formerly AN-152), in patients with advanced o...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...cts of Cost Savings Initiatives Quantified - ...dance -, HOPKINTON, Mass., April 24 Caliper Life...er of tools and services for,drug discovery and li...ented a plan to consolidate its west coast busines...improve productivity and effectiveness of,its rese...
...RY, N.J., April 24 Amicus Therapeutics,Inc. (Nasd... President and,Chief Executive Officer, will prese... Healthcare Unplugged Conference on Wednesday, Apr...in Key Biscayne, Florida., The presentation will ...icus, website at http://www.amicustherapeutics.co...
..., Pa., April 24 Cephalon, Inc.,(Nasdaq: CEPH ) t...fication,Notice Letter relating to an Abbreviated ...Food and Drug Administration (FDA) by Watson,Labor...ell a generic,version of FENTORA(R) (fentanyl bucc...leges that the U.S. Patent Numbers 6,200,604 and 6...
Other Biology Technology:Caliper Life Sciences Reports West Coast Consolidation of Operations 2Caliper Life Sciences Reports West Coast Consolidation of Operations 3Caliper Life Sciences Reports West Coast Consolidation of Operations 4Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 2Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 3
(Date:11/26/2009)...re some of the Ocean,s most distinctive residents....strange head shape, says Michelle McComb from Flo...he shark,s vision. ,Perhaps their visual field has...Comb, giving the sharks excellent stereovision and...here were two schools of thought on this theory. I...
(Date:11/26/2009)...t in eight European countries has shown that closi...andemic could have a significant role in reducing ...pen access journal BMC Infectious Diseases compa... weekends/holidays, finding that they were reduced...t and Antwerp University, Belgium, led a team of E...
(Date:11/26/2009)...esistant Staphylococcus Aureus ) and other drug-r...emperature plasma prototype devices have been deve...tericidal cocktails. , Two prototype devices hav...f healthy skin (e.g. hands and feet) in hospitals ... threat; and another to shoot bacteria-killing age...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 1DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 2DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 3FDA Accepts Final Section of NDA Filing for LUCASSIN 28R 29 48733 1FDA Accepts Final Section of NDA Filing for LUCASSIN 28R 29 48733 2Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 1Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 2Volvo Invites Customers to Cut Their Service Bills While Supporting Pediatric Cancer Research 48729 3
...ltimore, MD) In the first neuroimaging study to e...searchers at the Kennedy Krieger Institute have un...l basis of autism. The study, published online in ...ss, compared the brain activity of children with h...ing peers while performing a simple motor tasktapp...
... biotechnologies that allow scientists to quickly ...le DNA analysis are being creatively deployed for ...isease. , The University of Ghana, supported by t... is pioneering the use of DNA "barcodes" to map me... lymphatic filariasis (LF), commonly known as elep...
...e human brain stores some kinds of memories for a ...t things, our gray matter also creates temporary m...the few seconds these visual memories exist. For d...memories don,t suddenly disappear, but grow gradua...nds. , Now researchers at the University of Calif...
Other Biology News:First neuroimaging study examining motor execution in children with autism reveals new insights 2First neuroimaging study examining motor execution in children with autism reveals new insights 3DNA barcoding of mosquito species deployed in bid to end elephantiasis 2DNA barcoding of mosquito species deployed in bid to end elephantiasis 3DNA barcoding of mosquito species deployed in bid to end elephantiasis 4Some short-term memories die suddenly, no fading 2
Goat Anti-T7 tag Polyclonal Antibody, Agarose Conjugated from GeneTex
Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-C/EBPdelta Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: